In St. Paul, Minnesota, long winters and limited specialist access can make weight management harder than it should be. Mounjaro® is the FDA-approved Injectable pen Tirzepatide product manufactured by Eli Lilly since 2022. Weight Method offers a separate option: licensed Minnesota providers evaluate eligible patients via telehealth and prescribe compounded Tirzepatide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Tirzepatide is not FDA-approved. The Weight Method program for St. Paul starts at $329/month — medication, provider evaluation, ongoing care, and shipping included.
GLP-1 treatment prescribed by licensed providers. Delivered to your door.
Free consultation · No commitment · Results in weeks
From 2,000+ patients · St. Paul is already seeing results
GLP-1 weight-loss treatment available to eligible patients in St. Paul, MN. Weight Method offers compounded tirzepatide, prescribed by licensed providers, from $329/month with virtual consultations and direct-to-door shipping.
For many people in St. Paul, diet and exercise alone have not produced lasting results — and that is not a failure of willpower. Tirzepatide addresses hormonal drivers involved in body weight regulation. Mounjaro® is the FDA-approved Injectable pen Tirzepatide product by Eli Lilly, approved in 2022 for Type 2 diabetes. Weight Method offers a separate telehealth program: licensed providers evaluate eligible patients and prescribe compounded Tirzepatide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Tirzepatide is not FDA-approved. The program is priced at $329/month, including the evaluation, the medication, ongoing care, and home delivery to St. Paul.
City life in St. Paul brings convenience in many forms, but it also brings sedentary desk jobs, food delivery temptation, and stress-driven eating patterns that make weight management difficult. Tirzepatide therapy works at the biological level — reducing hunger and cravings — so St. Paul residents can make better choices even during their busiest days. Weight Method prescribes compounded Tirzepatide, dispensed by a U.S.-licensed 503A pharmacy, at $329/month through virtual consultations that fit into a lunch break. Compounded Tirzepatide is not FDA-approved.
Compounded GLP-1 medications dispensed by U.S.-licensed 503A pharmacies.

Compounded semaglutide. Once-weekly subcutaneous injection.

Compounded tirzepatide. Dual-action GLP-1/GIP, once-weekly subcutaneous injection.
Consult with a licensed provider in Minnesota and start Mounjaro from $329/month.
Get Started NowFree consultation. No commitment.